Business
Aptus Pharma Ltd. Press Release Apr 20 2026
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 27th April, 2026, inter alia, to consider and approve the audited Financial Results of the Company for the half year/Year ended 31st March, 2026 and to take on record the Auditor Report thereon.Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Company's securities has been closed and shall remain closed till 48 hours after the declaration of the said financial results.
About this update from Aptus Pharma Ltd.
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 27th April, 2026, inter alia, to consider and approve the audited Financial Results of the Company for the half year/Year ended 31st March, 2026 and to take on record the Auditor Report thereon.Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Company's securities has been closed and shall remain closed till 48 hours after the declaration of the said financial results. View Attachment